Inderal

Propranolol Hydrochloride, the active ingredient in Inderal, is a beta blocker presented as an oral tablet for systemic use. It lowers blood pressure, reduces heart workload, and is employed in the management of several cardiovascular and neurological conditions in adult patients.

GNH USA supplies Inderal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance.

Inderal (propranolol hydrochloride) is used to treat conditions within the cardiovascular and neurological disease families by modulating β‑adrenergic activity.

- Hypertension: lowers systemic blood pressure by decreasing heart rate and cardiac output. - Angina pectoris: reduces myocardial oxygen demand, relieving chest pain during exertion. - Cardiac arrhythmias: stabilises abnormal heart rhythms by slowing conduction through the AV node. - Myocardial infarction prophylaxis: decreases risk of recurrent heart attacks after an initial event. - Migraine prophylaxis: prevents migraine attacks by modulating vascular tone. - Essential tremor: diminishes tremor amplitude through central β‑adrenergic blockade.

Propranolol may cause a range of adverse reactions, which are grouped by frequency.

Common Side Effects: - Fatigue or tiredness - Dizziness or light‑headedness - Cold hands and feet - Gastrointestinal upset (nausea, abdominal discomfort) - Sleep disturbances or vivid dreams - Bradycardia (slow heart rate)

Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm, especially in asthmatic patients - Masking of hypoglycaemia symptoms in diabetics - Depression or mood changes

When prescribing Inderal, clinicians should observe several precautionary measures to ensure safe use.

- Cardiovascular assessment: evaluate heart rate and blood pressure before initiation. - Diabetes monitoring: monitor blood glucose as beta‑blockers may mask hypoglycaemia symptoms. - Abrupt discontinuation: taper the dose to avoid rebound tachycardia or hypertension. - Respiratory caution: use with care in patients with asthma or chronic obstructive pulmonary disease. - Renal/hepatic impairment: adjust dose in patients with reduced organ function. - Store at room temperature: keep in the original container, protect from moisture.

Propranolol interacts with several drug classes; some combinations should be avoided while others require close monitoring.

Major Interactions (Avoid): - Other non‑selective β‑blockers: additive β‑adrenergic blockade may cause severe bradycardia. - Calcium channel blockers (verapamil, diltiazem): combined effect can lead to marked heart block or hypotension. - Clonidine withdrawal: abrupt cessation while on propranolol may precipitate hypertensive crisis.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: may enhance antihypertensive effect, requiring blood pressure monitoring. - ACE inhibitors or ARBs: combined therapy can increase risk of hypotension, especially in volume‑depleted patients.